Niacin and heart disease: Prescriptions rise, but evidence lacks
Prescriptions for niacin have jumped in recent years, raising questions about whether the more than $900 million the United States now spends yearly on the vitamin is wise, given that it has failed to show benefits for preventing deaths from cardiovascular disease in the last two large clinical trials
Tags:
Niacin and heart disease: Prescriptions rise, but evidence lacks,
Cardiovascular Disease Latest News